200 related articles for article (PubMed ID: 37269534)
1. Vascular calcification in CKD: New insights into its mechanisms.
Ding N; Lv Y; Su H; Wang Z; Kong X; Zhen J; Lv Z; Wang R
J Cell Physiol; 2023 Jun; 238(6):1160-1182. PubMed ID: 37269534
[TBL] [Abstract][Full Text] [Related]
2. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
[TBL] [Abstract][Full Text] [Related]
3. Advances in pharmacotherapy for hyperphosphatemia in renal disease.
Spasovski G
Expert Opin Pharmacother; 2015; 16(17):2589-99. PubMed ID: 26374200
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease.
Huang M; Zheng L; Xu H; Tang D; Lin L; Zhang J; Li C; Wang W; Yuan Q; Tao L; Ye Z
J Mol Cell Cardiol; 2020 Jan; 138():256-268. PubMed ID: 31866376
[TBL] [Abstract][Full Text] [Related]
5. Vascular Calcification: An Important Understanding in Nephrology.
Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future therapy.
Pongsuwan K; Kusirisin P; Narongkiattikhun P; Chattipakorn SC; Chattipakorn N
J Cell Physiol; 2022 Dec; 237(12):4369-4396. PubMed ID: 36183389
[TBL] [Abstract][Full Text] [Related]
7. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
Filipska I; Winiarska A; Knysak M; Stompór T
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
[TBL] [Abstract][Full Text] [Related]
9. Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification .
Gross P; Six I; Kamel S; Massy ZA
Circ J; 2014; 78(10):2339-46. PubMed ID: 25077548
[TBL] [Abstract][Full Text] [Related]
10. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
Ishiwata R; Morimoto Y
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166323. PubMed ID: 34921974
[TBL] [Abstract][Full Text] [Related]
12. The ameliorative effect of terpinen-4-ol on ER stress-induced vascular calcification depends on SIRT1-mediated regulation of PERK acetylation.
Zhang Y; He L; Tu M; Huang M; Chen Y; Pan D; Peng J; Shen X
Pharmacol Res; 2021 Aug; 170():105629. PubMed ID: 34089864
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.
Voelkl J; Lang F; Eckardt KU; Amann K; Kuro-O M; Pasch A; Pieske B; Alesutan I
Cell Mol Life Sci; 2019 Jun; 76(11):2077-2091. PubMed ID: 30887097
[TBL] [Abstract][Full Text] [Related]
14. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.
Ruderman I; Hewitson TD; Smith ER; Holt SG; Wigg B; Toussaint ND
BMC Nephrol; 2020 Jul; 21(1):279. PubMed ID: 32677907
[TBL] [Abstract][Full Text] [Related]
15. The Key Role of Phosphate on Vascular Calcification.
Cozzolino M; Ciceri P; Galassi A; Mangano M; Carugo S; Capelli I; Cianciolo G
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30970562
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
17. Vascular calcification is associated with Wnt-signaling pathway and blood pressure variability in chronic kidney disease rats.
Liao R; Wang L; Li J; Sun S; Xiong Y; Li Y; Han M; Jiang H; Anil M; Su B
Nephrology (Carlton); 2020 Mar; 25(3):264-272. PubMed ID: 31709686
[TBL] [Abstract][Full Text] [Related]
18. SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease.
Dong QQ; Tu YC; Gao P; Liao QQ; Zhou P; Zhang H; Shu HP; Sun LL; Feng L; Yao LJ
Theranostics; 2024; 14(2):861-878. PubMed ID: 38169564
[No Abstract] [Full Text] [Related]
19. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure.
Cernaro V; Longhitano E; Calabrese V; Casuscelli C; Di Carlo S; Spinella C; Gembillo G; Santoro D
Expert Opin Pharmacother; 2023; 24(15):1737-1746. PubMed ID: 37527180
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a.
Caus M; Alonso-Montes C; Fernandez-Martin JL; Marti-Antonio M; Bozic M; Valdivielso JM
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1533-1548. PubMed ID: 37381989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
